Menu
GeneBe

STRADA

STE20 related adaptor alpha

Basic information

Region (hg38): 17:63682335-63741986

Links

ENSG00000266173NCBI:92335OMIM:608626HGNC:30172Uniprot:Q7RTN6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • polyhydramnios, megalencephaly, and symptomatic epilepsy (Strong), mode of inheritance: AR
  • polyhydramnios, megalencephaly, and symptomatic epilepsy (Strong), mode of inheritance: AR
  • polyhydramnios, megalencephaly, and symptomatic epilepsy (Supportive), mode of inheritance: AR
  • polyhydramnios, megalencephaly, and symptomatic epilepsy (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Polyhydramnios, megalencephaly, and symptomatic epilepsyARCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Endocrine; Neurologic; Obstetric; Renal17522105
The condition can affect the pregnancy (due to polyhydramnios) with the affected individual

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the STRADA gene.

  • Polyhydramnios, megalencephaly, and symptomatic epilepsy (326 variants)
  • not provided (15 variants)
  • Inborn genetic diseases (10 variants)
  • not specified (4 variants)
  • intellectual deficiency;Polyhydramnios;Epilepsy (1 variants)
  • Childhood epilepsy with centrotemporal spikes (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the STRADA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
70
clinvar
1
clinvar
74
missense
144
clinvar
3
clinvar
1
clinvar
148
nonsense
5
clinvar
2
clinvar
1
clinvar
8
start loss
0
frameshift
4
clinvar
4
clinvar
8
inframe indel
4
clinvar
4
splice donor/acceptor (+/-2bp)
3
clinvar
3
splice region
8
11
19
non coding
10
clinvar
51
clinvar
4
clinvar
65
Total 9 3 167 125 6

Highest pathogenic variant AF is 0.00000658

Variants in STRADA

This is a list of pathogenic ClinVar variants found in the STRADA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-63685671-G-C Benign (Jun 19, 2021)1181474
17-63685825-T-C Benign (Nov 12, 2018)1250681
17-63685848-A-G Benign (Jun 19, 2021)1236011
17-63688315-T-C Benign (Jun 20, 2021)1237797
17-63688530-A-C MAP3K3-related disorder Likely benign (Jan 23, 2024)3031148
17-63688813-A-G not specified Uncertain significance (Jul 05, 2023)2590217
17-63688839-C-T not specified Uncertain significance (Apr 14, 2022)2210387
17-63688843-G-A not specified Uncertain significance (Feb 28, 2023)2456808
17-63688851-G-A Benign (Apr 16, 2018)713294
17-63689097-T-G Benign (Jun 19, 2021)1225444
17-63689520-C-A Benign (Jun 19, 2021)1248554
17-63689571-G-A not specified Uncertain significance (Dec 05, 2022)2229691
17-63689605-C-T Benign (Feb 20, 2018)717040
17-63689632-G-C not specified Uncertain significance (Nov 16, 2021)2367957
17-63689638-G-A not specified Uncertain significance (Aug 08, 2023)2617493
17-63689640-G-A not specified Uncertain significance (Jan 26, 2023)2479253
17-63689690-A-G not specified Uncertain significance (Jan 03, 2024)3122937
17-63689721-A-G not specified Uncertain significance (Nov 09, 2022)2393576
17-63690291-G-A not specified Uncertain significance (Jan 02, 2024)3122938
17-63690320-G-A not specified Uncertain significance (Jul 19, 2023)2612964
17-63691202-C-A not specified Uncertain significance (Aug 09, 2021)2241632
17-63691212-C-G Verrucous hemangioma • Verrucous venous malformation Pathogenic/Likely pathogenic (Aug 27, 2023)1691386
17-63691733-G-C not specified Uncertain significance (Oct 13, 2023)3122939
17-63691819-G-A not specified Uncertain significance (Jun 29, 2022)2365092
17-63691851-G-A not specified Uncertain significance (Dec 19, 2022)2337421

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
STRADAprotein_codingprotein_codingENST00000336174 1239139
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000004480.9911257040441257480.000175
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.491902570.7390.00001452830
Missense in Polyphen70102.450.683231150
Synonymous0.509961030.9360.00000615844
Loss of Function2.361326.00.5010.00000151264

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002100.000207
Ashkenazi Jewish0.000.00
East Asian0.0003810.000381
Finnish0.0003300.000323
European (Non-Finnish)0.0001940.000193
Middle Eastern0.0003810.000381
South Asian0.00006540.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation. {ECO:0000269|PubMed:12805220, ECO:0000269|PubMed:14517248, ECO:0000269|PubMed:19892943}.;
Disease
DISEASE: Note=A homozygous 7-kb deletion involving STRADA is a cause of a syndrome characterized by polyhydramnios, megalencephaly and symptomatic epilepsy.;
Pathway
mTOR signaling pathway - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);AMP-activated Protein Kinase (AMPK) Signaling;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Signal Transduction;Energy dependent regulation of mTOR by LKB1-AMPK;mTOR signalling;LKB1 signaling events (Consensus)

Recessive Scores

pRec
0.132

Intolerance Scores

loftool
0.801
rvis_EVS
0.06
rvis_percentile_EVS
58.74

Haploinsufficiency Scores

pHI
hipred
Y
hipred_score
0.756
ghis
0.396

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.775

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Strada
Phenotype

Gene ontology

Biological process
MAPK cascade;protein phosphorylation;protein export from nucleus;cell cycle arrest;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;neuron projection morphogenesis;positive regulation of protein serine/threonine kinase activity
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol
Molecular function
protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;kinase binding;protein kinase activator activity;protein serine/threonine kinase activator activity